| Stealth Me. PEG‐PLA nanoparticles avoid uptake by the mononuclear phagocytes system D Bazile, C Prud'homme, MT Bassoullet, M Marlard, G Spenlehauer, ... Journal of pharmaceutical sciences 84 (4), 493-498, 1995 | 789 | 1995 |
| The design of nanoparticles obtained by solvent evaporation: a comprehensive study S Desgouilles, C Vauthier, D Bazile, J Vacus, JL Grossiord, M Veillard, ... Langmuir 19 (22), 9504-9510, 2003 | 273 | 2003 |
| Body distribution of fully biodegradable [14C]-poly (lactic acid) nanoparticles coated with albumin after parenteral administration to rats DV Bazile, C Ropert, P Huve, T Verrecchia, M Mariard, A Frydman, ... Biomaterials 13 (15), 1093-1102, 1992 | 256 | 1992 |
| Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators M Vittaz, D Bazile, G Spenlehauer, T Verrecchia, M Veillard, F Puisieux, ... Biomaterials 17 (16), 1575-1581, 1996 | 255 | 1996 |
| Non-stealth (poly (lactic acid/albumin)) and stealth (poly (lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers T Verrecchia, G Spenlehauer, DV Bazile, A Murry-Brelier, Y Archimbaud, ... Journal of Controlled Release 36 (1-2), 49-61, 1995 | 248 | 1995 |
| Process for preparing nanoparticles G Spenleuhauer, D Bazile, M Veillard, C Prud'Homme, JP Michalon US Patent 5,766,635, 1998 | 164 | 1998 |
| Adsorption/desorption of human serum albumin at the surface of poly (lactic acid) nanoparticles prepared by a solvent evaporation process T Verrecchia, P Huve, D Bazile, M Veillard, G Spenlehauer, P Couvreur Journal of biomedical materials research 27 (8), 1019-1028, 1993 | 101 | 1993 |
| Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeutics LH Reddy, D Bazile Advanced Drug Delivery Reviews 71, 34-57, 2014 | 93 | 2014 |
| Degradation of poly (D, L-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII) FB Landry, DV Bazile, G Spenlehauer, M Veillard, J Kreuter Biomaterials 17 (7), 715-723, 1996 | 92 | 1996 |
| Comparison of the safety profiles of PLA50 and Me. PEG-PLA50 nanoparticles after single dose intravenous administration to rat JP Plard, D Bazile Colloids and surfaces B: Biointerfaces 16 (1-4), 173-183, 1999 | 82 | 1999 |
| Y-shaped mPEG-PLA cabazitaxel conjugates: well-controlled synthesis by organocatalytic approach and self-assembly into interface drug-loaded core–corona nanoparticles F Bensaid, O Thillaye du Boullay, A Amgoune, C Pradel, ... Biomacromolecules 14 (4), 1189-1198, 2013 | 70 | 2013 |
| Oral delivery of diabetes peptides—Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context HR Lakkireddy, M Urmann, M Besenius, U Werner, T Haack, P Brun, ... Advanced drug delivery reviews 106, 196-222, 2016 | 66 | 2016 |
| Influence of lipid nanocapsules composition on their aptness to freeze-drying C Dulieu, D Bazile Pharmaceutical research 22, 285-292, 2005 | 60 | 2005 |
| Precise engineering of multifunctional PEGylated polyester nanoparticles for cancer cell targeting and imaging N Mackiewicz, J Nicolas, N Handké, M Noiray, J Mougin, C Daveu, ... Chemistry of Materials 26 (5), 1834-1847, 2014 | 57 | 2014 |
| α-DNA VIII: thermodynamic parameters of complexes formed between the oligo-alpha-deoxynucleotides: α-d (GGAAGG) and α-d (CCTTCC) and their complementary oligo-beta … J Paoletti, D Bazile, F Morvan, JL Imbach, C Paoletti Nucleic acids research 17 (7), 2693-2704, 1989 | 53 | 1989 |
| Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin E Presas, F McCartney, E Sultan, C Hunger, S Nellen, CV Alvarez, ... Journal of controlled release 286, 402-414, 2018 | 51 | 2018 |
| Encapsulation of oligonucleotides in stealth Me.PEG-PLA50 nanoparticles by complexation with structured oligopeptides C Emile, D Bazile, F Herman, C Helene, M Veillard Drug Delivery 3 (3), 187-195, 1996 | 49 | 1996 |
| Influence of coating agents on the degradation of poly (d, l-lactic acid) nanoparticles in model digestive fluids (USP XXII) FB Landry, DV Bazile, G Spenlehauer, M Veillard, J Kreuter STP pharma sciences 6 (3), 195-202, 1996 | 47 | 1996 |
| Bridging communities in the field of nanomedicine B Halamoda-Kenzaoui, S Baconnier, T Bastogne, D Bazile, P Boisseau, ... Regulatory Toxicology and Pharmacology 106, 187-196, 2019 | 41 | 2019 |
| Effect of cryoprotectant and freeze-drying process on the stability of W/O/W emulsions MJ Choi, S Briançon, D Bazile, A Royere, SG Min, H Fessi Drying technology 25 (5), 809-819, 2007 | 39 | 2007 |
